368 related articles for article (PubMed ID: 7694275)
1. Molecular modeling and site-directed mutagenesis of an anti-phosphotyrosine antibody predicts the combining site and allows the detection of higher affinity interactions.
Ruff-Jamison S; Glenney JR
Protein Eng; 1993 Aug; 6(6):661-8. PubMed ID: 7694275
[TBL] [Abstract][Full Text] [Related]
2. Requirement for both H and L chain V regions, VH and VK joining amino acids, and the unique H chain D region for the high affinity binding of an anti-phosphotyrosine antibody.
Ruff-Jamison S; Glenney JR
J Immunol; 1993 Apr; 150(8 Pt 1):3389-96. PubMed ID: 7682239
[TBL] [Abstract][Full Text] [Related]
3. Heavy and light chain variable region sequences and antibody properties of anti-phosphotyrosine antibodies reveal both common and distinct features.
Ruff-Jamison S; Campos-González R; Glenney JR
J Biol Chem; 1991 Apr; 266(10):6607-13. PubMed ID: 1706720
[TBL] [Abstract][Full Text] [Related]
4. Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand.
Mallender WD; Carrero J; Voss EW
J Biol Chem; 1996 Mar; 271(10):5338-46. PubMed ID: 8621386
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
Li Y; Li H; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
[TBL] [Abstract][Full Text] [Related]
6. Selection of antibody single-chain variable fragments with improved carbohydrate binding by phage display.
Deng SJ; MacKenzie CR; Sadowska J; Michniewicz J; Young NM; Bundle DR; Narang SA
J Biol Chem; 1994 Apr; 269(13):9533-8. PubMed ID: 8144539
[TBL] [Abstract][Full Text] [Related]
7. A comparative analysis of the immunological evolution of antibody 28B4.
Yin J; Mundorff EC; Yang PL; Wendt KU; Hanway D; Stevens RC; Schultz PG
Biochemistry; 2001 Sep; 40(36):10764-73. PubMed ID: 11535051
[TBL] [Abstract][Full Text] [Related]
8. Design of interchain disulfide bonds in the framework region of the Fv fragment of the monoclonal antibody B3.
Jung SH; Pastan I; Lee B
Proteins; 1994 May; 19(1):35-47. PubMed ID: 8066084
[TBL] [Abstract][Full Text] [Related]
9. Modeling the antigen combining site of an anti-dinitrophenyl antibody, ANO2.
Bassolino-Klimas D; Bruccoleri RE; Subramaniam S
Protein Sci; 1992 Nov; 1(11):1465-76. PubMed ID: 1303765
[TBL] [Abstract][Full Text] [Related]
10. Affinity maturation increases the stability and plasticity of the Fv domain of anti-protein antibodies.
Acierno JP; Braden BC; Klinke S; Goldbaum FA; Cauerhff A
J Mol Biol; 2007 Nov; 374(1):130-46. PubMed ID: 17916365
[TBL] [Abstract][Full Text] [Related]
11. 1.85 A structure of anti-fluorescein 4-4-20 Fab.
Whitlow M; Howard AJ; Wood JF; Voss EW; Hardman KD
Protein Eng; 1995 Aug; 8(8):749-61. PubMed ID: 8637844
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an anti-CD44 single-chain FV antibody that stimulates natural killer cell activity and induces TNF alpha release.
Tan PH; Sandmaier BM; Stayton PS
Immunol Invest; 1995 Nov; 24(6):907-26. PubMed ID: 8575837
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an anti-digoxin antibody binding site by site-directed in vitro mutagenesis.
Near RI; Mudgett-Hunter M; Novotny J; Bruccoleri R; Ng SC
Mol Immunol; 1993 Mar; 30(4):369-77. PubMed ID: 8455637
[TBL] [Abstract][Full Text] [Related]
14. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
Pruett PS; Air GM
Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization and structural modeling of immunoglobulin variable regions from murine monoclonal antibodies specific for hepatitis B virus surface antigen.
Lohman KL; Kieber-Emmons T; Kennedy RC
Mol Immunol; 1993 Oct; 30(14):1295-306. PubMed ID: 7692242
[TBL] [Abstract][Full Text] [Related]
16. Antibodies specific for (6-4) DNA photoproducts: cloning, antibody modeling and construction of a single-chain Fv derivative.
Morioka H; Miura H; Kobayashi H; Koizumi T; Fujii K; Asano K; Matsunaga T; Nikaido O; Stewart JD; Ohtsuka E
Biochim Biophys Acta; 1998 Jun; 1385(1):17-32. PubMed ID: 9630483
[TBL] [Abstract][Full Text] [Related]
17. Primary structure of light and heavy chain variable regions of antibodies recognizing phosphorylated vimentins.
Tsujino S; Sekimata M; Inagaki N; Kamie Y; Higashihara M; Kurokawa K; Imajoh-Ohmi S; Inagaki M
Biochem Biophys Res Commun; 1996 Feb; 219(2):633-7. PubMed ID: 8605039
[TBL] [Abstract][Full Text] [Related]
18. Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38.
Benhar I; Padlan EA; Jung SH; Lee B; Pastan I
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12051-5. PubMed ID: 7991583
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of anti-Hen egg white lysozyme antibody (HyHEL-10) Fv-antigen complex. Local structural changes in the protein antigen and water-mediated interactions of Fv-antigen and light chain-heavy chain interfaces.
Kondo H; Shiroishi M; Matsushima M; Tsumoto K; Kumagai I
J Biol Chem; 1999 Sep; 274(39):27623-31. PubMed ID: 10488102
[TBL] [Abstract][Full Text] [Related]
20. Structural predictions of the binding site architecture for monoclonal antibody NC6.8 using computer-aided molecular modeling, ligand binding, and spectroscopy.
Viswanathan M; Anchin JM; Droupadi PR; Mandal C; Linthicum DS; Subramaniam S
Biophys J; 1995 Sep; 69(3):741-53. PubMed ID: 8519975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
